Women with a particular factor V gene mutation may have an increased risk of blood clots during adjuvant tamoxifen therapy

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1052, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective

By Karnon Jonathan  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 237-250

Adis International

Access to resources Recommend Favorite

Tegafur/uracil plus tamoxifen boosts adjuvant therapy

By  

Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Sulfamethizole use during pregnancy may be associated with an increased risk of miscarriage

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Tamoxifen may have a beneficial biochemical effect in primary biliary cirrhosis

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Tamoxifen-treated women at risk for oesophageal or gastric cancer?

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite